海角社区

1.1. Team Composition:

The nominated Principal Investigator (PI) must hold a primary appointment at 海角社区 or one of 海角社区鈥檚 affiliated hospitals or research institutes (e.g. the Research Institute of the 海角社区 Health Centre, Montreal Neurological Institute, Jewish General Hospital). The PI鈥檚 location is defined as the primary site where their research team is based.

In addition to the nominated PI, proposals may include one or more Co-Principal Investigators (Co-PIs) from within or outside the 海角社区 community.

Additional collaborators may be included as needed to accomplish the proposed work and may include on-campus or off-campus partners, senior faculty, clinical staff, postdoctoral trainees, and international collaborators.

Subcontracts to investigators outside 海角社区 and its affiliated institutions may be permitted when appropriately justified and are subject to GHP approval and applicable institutional policies.

1.2. Eligibility:

The Principal Investigators must meet the eligibility requirements of a University Researcher or Clinical University Researcher, as defined by the Fonds de Recherche du Qu茅bec (). In accordance with the appropriate RI-MUHC and 海角社区 policies, a researcher devotes more than 50% of their time to research and teaching.

A researcher may participate in only one Catherine Wang SFG proposal per competition cycle, either as a PI or Co-PI.

A researcher may hold a maximum of two active GHP-funded seed grants at any given time, including Steinberg Fund for Interdisciplinary Global Health Research seed grants, as either PI or Co-PI.

1.3. Non-Eligible Projects:

The following are examples of projects that are not eligible under this funding opportunity:

• Research projects primarily focused on infectious diseases, including epidemiology, prevention, diagnosis, treatment, or control, regardless of setting.
• Fundamental laboratory or bench research that does not demonstrate a clear translational pathway or relevance to global health outcomes. Applicants proposing laboratory-based work must clearly describe the translational focus.
• Early-stage engineering or technology development that is not sufficiently advanced for validation in human participants, human samples, and/or relevant clinical or field settings.
• Projects that are deemed highly clinical without any global health equity focus
• Research activities that are already supported by other sources of funding.
• Gap funding intended to bridge support between external grants or contracts.
• Projects that are not clearly aligned with health equity.

Please note: GHP reserves the right to administratively screen proposals for eligibility. Only proposals deemed eligible and within the scope of the competition will be sent for peer review.

1.4 Available Funds and Grant Term

In the current round, funds are available to support up to two grants, for a maximum of $25,000 per award. The grant term must be between 12-24 months (inclusive). Funds will be disbursed in one payment at the start of the grant term, subject to completion of any required institutional approvals. Grants are non-renewable, and any unspent funds must be returned to GHP at the end of the grant term in accordance with the grant agreement.

The deadline for submissions is Sunday, April 19, 2026 at 11:59 PM EDT.

All applications must be submitted by email in PDF format (one single, consolidated PDF) to ghp-progmanager.med [at] mcgill.ca.

All application materials must be submitted in English.

Please include 鈥�2026 Catherine Wang SFG鈥� in the email subject line.

Late submissions will not be accepted.

Applicants with questions regarding eligibility or submission requirements are encouraged to contact GHP in advance of the submission deadline at ghp-progmanager.med [at] mcgill.ca.

Applications must include a consolidated Application Package (maximum 9.5 pages). Additional pages beyond the stated limits will not be reviewed. Applicants must use the headings below and respect the required page length for each section. CVs and signature page(s) are submitted as part of the overall application but do not count toward the 9.5-page limit. Applications must use a minimum 11-point font and standard margins.

4.1. Project Information

• 1.1 Project title
• 1.2 Study site(s)
• 1.3 Lay summary (max 200 words)
• 1.4 Nominated Principal Investigator: title/position, department, location, email
• 1.5 Co-Principal Investigators (if applicable): academic institution, title/position, department, location, email
• 1.6 Collaborators
• 1.7 Project duration and budget requested

4.2. Project Description (3 pages, including figures; references excluded)

2.1 Research Rationale:

• Explain the research question and concept, and justify the novelty of the proposed work.

2.2 Primary Deliverables: Provide up to three deliverables in brief bullet points.

2.3 Background Research (last 5 years)

• Summarize previous work leading up to the proposed project. Preliminary data is not required. Projects with extensive preliminary data should be submitted to traditional granting agencies.

2.4 Proposed Research Activities

• Briefly describe the proposed study and timeline. Use language that is comprehensible to an interdisciplinary audience.
• Provide clear milestones at 12 months and at project end (up to 24 months) that can be used to assess measurable progress and that demonstrate ongoing collaboration between the Co-PIs (where applicable).
• Describe anticipated research outputs and their potential impact. Where possible, include metrics and avoid overly general statements such as new knowledge, better understanding, or highly qualified personnel (HQP) training.

4.3. Project Team - Ability of team to Implement the project (1 page)

• Describe the expertise and roles of Co-PIs, collaborators, trainees, and/or research associates. Explain why the proposed team is well positioned to deliver the project.
• Describe how Equity, Diversity and Inclusion (EDI) considerations are reflected in the project team (two useful resources听are the听 and from听)
• See sub-section 7 for CV requirements.

4.4. Plan for Seeking Extramural Funding (0.5 page)

• One of the objectives of the Dr. Catherine Wang SFG in Global Health is to enable researchers to pursue external (extramural) funding by leveraging the data, partnerships, and experience gained through the seed grant.
• Describe the anticipated external funding opportunities that will be pursued following completion of the seed grant, and the anticipated submission timeline(s).
• Briefly describe how the seed grant will position the project for longer-term impact and external funding success (e.g., pilot data generation, feasibility testing, partnership development, refinement of methods, team-building, or other planned outputs).

4.5. Budget (1 page)

• Provide a detailed budget with brief justification covering the 12-24 month grant term. The maximum budget request is $25,000.

4.6. References (1 page)

4.7. CVs & Signature page

• Attach the CVs of the nominated PI and up to two additional key team members (maximum of 3 CVs total). CVs must be no more than 3 pages per team member and must be submitted in PDF format.
• Please have all Co-PIs sign to acknowledge their role in the project (Signature Page Template).

All budget items must comply with the policies and guidelines of the nominated PI鈥檚 institution, as well as the Tri-Agency Financial Administration Guide (TAFAG), and must directly align with the activities outlined in Section 2.4.

Eligible costs include:

• Salary support for trainees and research personnel (including benefits)
• Materials and supplies (consumables)
• Core or platform fees for project-related samples or data
• Data evaluation costs by appropriate research experts
• Small equipment (up to $7,000 total per project)
• Project-related travel that is directly required to carry out the proposed work

Ineligible costs include:

• Salaries of Principal Investigators
• Conference-related travel
• Indirect costs/overhead

Final decisions regarding budget eligibility will be made by GHP leadership.

6.1. Assessment Criteria

SFG submissions will be evaluated according to the following equal-weighted assessment criteria:

• Originality and innovation of the proposed research
• Well-defined research outputs and metrics, appropriate for the career stage(s) of the applicant team
• Clearly identified potential for impact and/or translation into policy/practice
• Focus on health equity and the needs and challenges of vulnerable or under-served populations
• Feasibility of the proposed research within the grant term and budget
• Expertise of the project leadership and overall project team
• Strength of the plan to pursue external (extramural) funding using the data and experience gained through the seed grant

6.2. Review Process

Submissions will be reviewed as follows:听

• Step 1 -听Administrative Review (Due Diligence):听

  • GHP will conduct an administrative review of submissions to confirm eligibility and verify that all required elements of the application package have been included. Submissions that do not comply will be removed from further consideration and applicants will be notified of missing elements or deficiencies. There is no appeal following this review.

• Step 2 -听Scientific Review Committee:听

  • A Scientific Review Committee (SRC) composed of members external to the 海角社区 community will evaluate and rank submissions according to the Assessment Criteria (Section 6.1) and provide recommendations regarding the top ranked submissions.

• Step 3 -听Approval by GHP:听

  • The GHP Director will validate the review process, consider the recommendations of the SRC, and approve the final list of awards, up to a maximum of $25,000 per proposal and subject to available funding ($50,000 in the current round).

• Conflict of Interest (COI): Team Composition:

  • GHP will apply a COI policy to ensure that individuals participating in the review process do not have a conflict of interest. Any person declaring a COI, or a potential COI, will be required to recuse themselves from the review process. COIs will be defined using the CIHR definition available at: .

GHP will contact the nominated PI with the funding decision comprising one of the following outcomes:

• Approved as submitted.
• Approved with conditions and/or recommendations to be incorporated into the project activities.
• Not approved, with inclusion of any feedback provided by the SRC (where available).

A Grant Agreement and Fund Release Agreement Form will be issued to the nominated PI outlining the terms and conditions of the award. All Co-PIs will be required to sign and return the agreement(s) to confirm acceptance of the award and its terms.

Where applicable, documentation of required research ethics approval(s) will be required prior to the release of funds.

The nominated Principal Investigator (PI) will be required to submit a brief progress report (template format) at the 12-month mark.

The nominated PI will also be required to submit a final narrative and financial report within 30 days of the end of the grant term, using a template to be provided by GHP.

• Catherine Wang SFG Request for Proposals (PDF) (EN)
• Catherine Wang SFG Request for Proposals (PDF) (FR)
• Signature Page (PDF)